Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Apr 15;97(8):1874–1883. doi: 10.1172/JCI118618

Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.

I Rauly 1, N Saint-Laurent 1, N Delesque 1, L Buscail 1, J P Estéve 1, N Vaysse 1, C Susini 1
PMCID: PMC507256  PMID: 8621771

Abstract

The somatostatin receptor subtype sst2 mediates both activation of a tyrosine phosphatase activity and inhibition of cell proliferation induced by somatostatin analogues. In the absence of exogenous ligand, expression of sst2 in NIH 3T3 cells resulted in inhibition of cell growth. Polymerase chain reaction coupled to reverse transcription demonstrated that expression of sst2 in NIH 3T3 cells stimulated the expression of preprosomatostatin mRNA accompanied by a production of immunoreactive somatostatin-like peptide which corresponded predominantly to somatostatin 14. Moreover anti-somatostatin antibodies suppressed sst2-promoted inhibition of cell proliferation. Inhibition of cell proliferation associated with increased secretion of somatostatin-like immunoreactivity was also observed after expression of sst2 in human pancreatic tumor cells BxPC3 devoid of endogenous receptors. In addition, expression of sst2 in NIH 3T3 cells was associated with constitutive activation of tyrosine phosphatase PTP1C that resulted from enhanced expression of the protein. Blocking of PTP1C tyrosine phosphatase activity with orthovanadate or that of PTP1C protein with antisense PTP1C oligonucleotides decreased the sst2-induced inhibition of cell proliferation. These results, taken together, show that expression of sst2 in NIH 3T3 cells generated a negative autocrine loop by stimulating sst2 ligand production and amplifying PTP1C sst2-transducer. Sst2/ligand may function as a determinant factor involved in the negative growth control of cells.

Full Text

The Full Text of this article is available as a PDF (264.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguila M. C., Dees W. L., Haensly W. E., McCann S. M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11485–11489. doi: 10.1073/pnas.88.24.11485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alonso S., Minty A., Bourlet Y., Buckingham M. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol. 1986;23(1):11–22. doi: 10.1007/BF02100994. [DOI] [PubMed] [Google Scholar]
  3. Amherdt M., Patel Y. C., Orci L. Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest. 1987 Nov;80(5):1455–1458. doi: 10.1172/JCI113225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bensaïd M., Tahiri-Jouti N., Cambillau C., Viguerie N., Colas B., Vidal C., Tauber J. P., Estève J. P., Susini C., Vaysse N. Basic fibroblast growth factor induces proliferation of a rat pancreatic cancer cell line. Inhibition by somatostatin. Int J Cancer. 1992 Mar 12;50(5):796–799. doi: 10.1002/ijc.2910500522. [DOI] [PubMed] [Google Scholar]
  5. Bruno J. F., Xu Y., Song J., Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11151–11155. doi: 10.1073/pnas.89.23.11151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buscail L., Delesque N., Estève J. P., Saint-Laurent N., Prats H., Clerc P., Robberecht P., Bell G. I., Liebow C., Schally A. V. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2315–2319. doi: 10.1073/pnas.91.6.2315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buscail L., Estève J. P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A. M., Bell G. I., Schally A. V., Vaysse N., Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1580–1584. doi: 10.1073/pnas.92.5.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cambillau C., Rauly I., Sarfati P., Saint-Laurent N., Esteve J. P., Fanjul M., Svoboda M., Prats H., Hollande E., Vaysse N. Regulation of the src homology 2 domain-containing protein tyrosine phosphatase PTP1C by glucocorticoids in rat pancreatic AR42J cells. Endocrinology. 1995 Dec;136(12):5476–5484. doi: 10.1210/endo.136.12.7588298. [DOI] [PubMed] [Google Scholar]
  9. Chayvialle J. A., Miyata M., Rayford P. L., Thompson J. C. Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs. Gastroenterology. 1980 Nov;79(5 Pt 1):844–852. [PubMed] [Google Scholar]
  10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  11. Fuhrmann G., Heilig R., Kempf J., Ebel A. Nucleotide sequence of the mouse preprosomatostatin gene. Nucleic Acids Res. 1990 Mar 11;18(5):1287–1287. doi: 10.1093/nar/18.5.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kondoh G., Hayasaka N., Li Q., Nishimune Y., Hakura A. An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis. Oncogene. 1995 Jan 19;10(2):341–347. [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Lamberts S. W., Krenning E. P., Reubi J. C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 1991 Nov;12(4):450–482. doi: 10.1210/edrv-12-4-450. [DOI] [PubMed] [Google Scholar]
  15. Law S. F., Woulfe D., Reisine T. Somatostatin receptor activation of cellular effector systems. Cell Signal. 1995 Jan;7(1):1–8. doi: 10.1016/0898-6568(94)00064-i. [DOI] [PubMed] [Google Scholar]
  16. Levy L., Bourdais J., Mouhieddine B., Benlot C., Villares S., Cohen P., Peillon F., Joubert D. Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas. J Clin Endocrinol Metab. 1993 Jan;76(1):85–90. doi: 10.1210/jcem.76.1.8093621. [DOI] [PubMed] [Google Scholar]
  17. Lewin M. J. The somatostatin receptor in the GI tract. Annu Rev Physiol. 1992;54:455–468. doi: 10.1146/annurev.ph.54.030192.002323. [DOI] [PubMed] [Google Scholar]
  18. Liebow C., Reilly C., Serrano M., Schally A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2003–2007. doi: 10.1073/pnas.86.6.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matozaki T., Uchida T., Fujioka Y., Kasuga M. Src kinase tyrosine phosphorylates PTP1C, a protein tyrosine phosphatase containing Src homology-2 domains that down-regulates cell proliferation. Biochem Biophys Res Commun. 1994 Oct 28;204(2):874–881. doi: 10.1006/bbrc.1994.2541. [DOI] [PubMed] [Google Scholar]
  20. Nelson J., Cremin M., Murphy R. F. Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin. Br J Cancer. 1989 May;59(5):739–742. doi: 10.1038/bjc.1989.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. O'Carroll A. M., Lolait S. J., König M., Mahan L. C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol. 1992 Dec;42(6):939–946. [PubMed] [Google Scholar]
  22. Pan M. G., Florio T., Stork P. J. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science. 1992 May 22;256(5060):1215–1217. doi: 10.1126/science.256.5060.1215. [DOI] [PubMed] [Google Scholar]
  23. Park J., Chiba T., Yokotani K., DelValle J., Yamada T. Somatostatin receptors on canine fundic D-cells: evidence for autocrine regulation of gastric somatostatin. Am J Physiol. 1989 Aug;257(2 Pt 1):G235–G241. doi: 10.1152/ajpgi.1989.257.2.G235. [DOI] [PubMed] [Google Scholar]
  24. Patel Y. C., Galanopoulou A. Processing and intracellular targeting of prosomatostatin-derived peptides: the role of mammalian endoproteases. Ciba Found Symp. 1995;190:26–50. doi: 10.1002/9780470514733.ch3. [DOI] [PubMed] [Google Scholar]
  25. Patel Y. C., Murthy K. K., Escher E. E., Banville D., Spiess J., Srikant C. B. Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism. 1990 Sep;39(9 Suppl 2):63–69. doi: 10.1016/0026-0495(90)90214-w. [DOI] [PubMed] [Google Scholar]
  26. Plutzky J., Neel B. G., Rosenberg R. D. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1123–1127. doi: 10.1073/pnas.89.3.1123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Raynor K., Wang H. L., Dichter M., Reisine T. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems. Mol Pharmacol. 1991 Aug;40(2):248–253. [PubMed] [Google Scholar]
  28. Reichlin S. Somatostatin (second of two parts). N Engl J Med. 1983 Dec 22;309(25):1556–1563. doi: 10.1056/NEJM198312223092506. [DOI] [PubMed] [Google Scholar]
  29. Reubi J. C., Schaer J. C., Waser B., Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res. 1994 Jul 1;54(13):3455–3459. [PubMed] [Google Scholar]
  30. Reubi J. C., Waser B., Lamberts S. W., Mengod G. Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SRIH receptor content. J Clin Endocrinol Metab. 1993 Mar;76(3):642–647. doi: 10.1210/jcem.76.3.8095268. [DOI] [PubMed] [Google Scholar]
  31. Schally A. V. Oncological applications of somatostatin analogues. Cancer Res. 1988 Dec 15;48(24 Pt 1):6977–6985. [PubMed] [Google Scholar]
  32. Shen S. H., Bastien L., Posner B. I., Chrétien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature. 1991 Aug 22;352(6337):736–739. doi: 10.1038/352736a0. [DOI] [PubMed] [Google Scholar]
  33. Shultz L. D., Schweitzer P. A., Rajan T. V., Yi T., Ihle J. N., Matthews R. J., Thomas M. L., Beier D. R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 1993 Jul 2;73(7):1445–1454. doi: 10.1016/0092-8674(93)90369-2. [DOI] [PubMed] [Google Scholar]
  34. Sporn M. B., Roberts A. B. Autocrine secretion--10 years later. Ann Intern Med. 1992 Sep 1;117(5):408–414. doi: 10.7326/0003-4819-117-5-408. [DOI] [PubMed] [Google Scholar]
  35. Tahiri-Jouti N., Cambillau C., Viguerie N., Vidal C., Buscail L., Saint Laurent N., Vaysse N., Susini C. Characterization of a membrane tyrosine phosphatase in AR42J cells: regulation by somatostatin. Am J Physiol. 1992 Jun;262(6 Pt 1):G1007–G1014. doi: 10.1152/ajpgi.1992.262.6.G1007. [DOI] [PubMed] [Google Scholar]
  36. Taylor J. E., Theveniau M. A., Bashirzadeh R., Reisine T., Eden P. A. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides. 1994;15(7):1229–1236. doi: 10.1016/0196-9781(94)90146-5. [DOI] [PubMed] [Google Scholar]
  37. Uchida T., Matozaki T., Noguchi T., Yamao T., Horita K., Suzuki T., Fujioka Y., Sakamoto C., Kasuga M. Insulin stimulates the phosphorylation of Tyr538 and the catalytic activity of PTP1C, a protein tyrosine phosphatase with Src homology-2 domains. J Biol Chem. 1994 Apr 22;269(16):12220–12228. [PubMed] [Google Scholar]
  38. Viguerie N., Tahiri-Jouti N., Ayral A. M., Cambillau C., Scemama J. L., Bastié M. J., Knuhtsen S., Estève J. P., Pradayrol L., Susini C. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology. 1989 Feb;124(2):1017–1025. doi: 10.1210/endo-124-2-1017. [DOI] [PubMed] [Google Scholar]
  39. Weckbecker G., Raulf F., Stolz B., Bruns C. Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther. 1993 Nov;60(2):245–264. doi: 10.1016/0163-7258(93)90009-3. [DOI] [PubMed] [Google Scholar]
  40. White R. E., Schonbrunn A., Armstrong D. L. Somatostatin stimulates Ca(2+)-activated K+ channels through protein dephosphorylation. Nature. 1991 Jun 13;351(6327):570–573. doi: 10.1038/351570a0. [DOI] [PubMed] [Google Scholar]
  41. Yamada Y., Post S. R., Wang K., Tager H. S., Bell G. I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):251–255. doi: 10.1073/pnas.89.1.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yasuda K., Rens-Domiano S., Breder C. D., Law S. F., Saper C. B., Reisine T., Bell G. I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J Biol Chem. 1992 Oct 5;267(28):20422–20428. [PubMed] [Google Scholar]
  43. Yi T., Mui A. L., Krystal G., Ihle J. N. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol. 1993 Dec;13(12):7577–7586. doi: 10.1128/mcb.13.12.7577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zeggari M., Esteve J. P., Rauly I., Cambillau C., Mazarguil H., Dufresne M., Pradayrol L., Chayvialle J. A., Vaysse N., Susini C. Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem J. 1994 Oct 15;303(Pt 2):441–448. doi: 10.1042/bj3030441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. de Bruïne A. P., de Vries J. E., Dinjens W. N., Moerkerk P. T., van der Linden E. P., Pijls M. M., ten Kate J., Bosman F. T. Human Caco-2 cells transfected with c-Ha-Ras as a model for endocrine differentiation in the large intestine. Differentiation. 1993 May;53(1):51–60. doi: 10.1111/j.1432-0436.1993.tb00645.x. [DOI] [PubMed] [Google Scholar]
  46. van Hagen P. M., Krenning E. P., Kwekkeboom D. J., Reubi J. C., Anker-Lugtenburg P. J., Löwenberg B., Lamberts S. W. Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest. 1994 Feb;24(2):91–99. doi: 10.1111/j.1365-2362.1994.tb00972.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES